6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one and Insulin-Resistance

6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one has been researched along with Insulin-Resistance* in 1 studies

Other Studies

1 other study(ies) available for 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one and Insulin-Resistance

ArticleYear
Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.
    Journal of lipid research, 2011, Volume: 52, Issue:6

    The mechanism of FFA-induced insulin resistance is not fully understood. We have searched for effector molecules(s) in FFA-induced insulin resistance. Palmitic acid (PA) but not oleic acid (OA) induced insulin resistance in L6 myotubes through C-Jun N-terminal kinase (JNK) and insulin receptor substrate 1 (IRS-1) Ser307 phosphorylation. Inhibitors of ceramide synthesis did not block insulin resistance by PA. However, inhibition of the conversion of PA to lysophosphatidylcholine (LPC) by calcium-independent phospholipase A₂ (iPLA₂) inhibitors, such as bromoenol lactone (BEL) or palmitoyl trifluoromethyl ketone (PACOCF₃), prevented insulin resistance by PA. iPLA₂ inhibitors or iPLA₂ small interfering RNA (siRNA) attenuated JNK or IRS-1 Ser307 phosphorylation by PA. PA treatment increased LPC content, which was reversed by iPLA₂ inhibitors or iPLA₂ siRNA. The intracellular DAG level was increased by iPLA₂ inhibitors, despite ameliorated insulin resistance. Pertussis toxin (PTX), which inhibits LPC action through the G-protein coupled receptor (GPCR)/Gα(i), reversed insulin resistance by PA. BEL administration ameliorated insulin resistance and diabetes in db/db mice. JNK and IRS-1Ser307 phosphorylation in the liver and muscle of db/db mice was attenuated by BEL. LPC content was increased in the liver and muscle of db/db mice, which was suppressed by BEL. These findings implicate LPC as an important lipid intermediate that links saturated fatty acids to insulin resistance.

    Topics: Animals; Blood Proteins; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Silencing; Glucose; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver; Lysophosphatidylcholines; Mice; Mice, Knockout; Muscle Fibers, Skeletal; Naphthalenes; Palmitic Acid; Pertussis Toxin; Phospholipases A2, Calcium-Independent; Phosphorylation; Pyrones; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction

2011